News - Meda

Filter

Current filters:

Meda

Popular Filters

Sweden’s Meda rejects Mylan’s takeover overture

Sweden’s Meda rejects Mylan’s takeover overture

06-04-2014

After a day of rumor and speculation about a takeover approach from US generic firm Mylan, Swedish drugmaker…

GenericsMedaMergers & AcquisitionsMylan Laboratories

Meda acquires US respiratory company

02-09-2013

Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Meda expands collaboration with India's Cipla on Dymista

06-06-2013

Swedish drugmaker Meda (OMX: MEDA A) is broadening its collaboration with Indian pharmaceutical company…

Asia-PacificCiplaDymistaLicensingMedaPharmaceuticalRespiratory and PulmonaryRest of the WorldSouth America

US FDA lowers recommended dose for sleep drugs containing zolpidem

11-01-2013

The US Food and Drug Administration yesterday announced it is requiring the manufacturers of Ambien,…

AmbienAmbien CREdluarMedaNeurologicalNorth AmericaNovaDel PharmaPharmaceuticalRegulationSanofizolpidemZolpiMist

Jazz Pharma sells women's health business to Meda for $95 million

07-09-2012

US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Meda's Zyclara approved in the EU

29-08-2012

Sweden-based Meda (OMX: MEDA A) yesterday announced that the European Commission has granted marketing…

DermatologicalsEuropeMedaOncologyPharmaceuticalRegulationZyclara

Perrigo confirms ANDA filing for generic Astepro nasal spray

24-01-2012

US generic drugmaker Perrigo (Nasdaq: PRGO;TASE) says that it has filed an Abbreviated New Drug Application…

AsteproAzelastine HydrochlorideGenericsImpax LaboratoriesLegalMedaNorth AmericaPatentsPerrigoRegulationRespiratory and Pulmonary

EU Commission clears KKR acquisition of Pfizer Capsugel unit; Meda says no approach from Valeant

28-07-2011

Under European Union merger regulations, the European Commission has cleared the proposed acquisition…

CapsugelMedaMergers & AcquisitionsPfizerPharmaceuticalValeant Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top